AISLING CAPITAL MANAGEMENT LP
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | BBIO | 5.09M | $377.95M |
 | BMEA | 2.05M | $3.13M |
 | GLUE | 1.56M | $25.59M |
 | CMPS | 1.43M | $7.92M |
 | SNDX | 1.32M | $30.76M |
 | BBOT | 1.02M | $9.11M |
 | BCAX | 569K | $11.32M |
 | ACRS | 434K | $1.63M |
 | MRKR | 325K | $422.98K |
 | EPRX | 325K | $2.35M |
 | URGN | 108K | $1.94M |
 | OKUR | 89K | $366.83K |
 | SRRK | 77K | $3.79M |
BridgeBio Pharma, Inc.
BBIO
Shares Held
5.09M
Value
$377.95M
Biomea Fusion, Inc.
BMEA
Shares Held
2.05M
Value
$3.13M
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
1.56M
Value
$25.59M
COMPASS Pathways plc
CMPS
Shares Held
1.43M
Value
$7.92M
Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
1.32M
Value
$30.76M
BridgeBio Oncology Therapeutics Inc.
BBOT
Shares Held
1.02M
Value
$9.11M
Bicara Therapeutics Inc. Common Stock
BCAX
Shares Held
569K
Value
$11.32M
Aclaris Therapeutics, Inc.
ACRS
Shares Held
434K
Value
$1.63M
Marker Therapeutics, Inc.
MRKR
Shares Held
325K
Value
$422.98K
Eupraxia Pharmaceuticals Inc.
EPRX
Shares Held
325K
Value
$2.35M
UroGen Pharma Ltd.
URGN
Shares Held
108K
Value
$1.94M
OnKure Therapeutics, Inc.
OKUR
Shares Held
89K
Value
$366.83K
Scholar Rock Holding Corporation
SRRK
Shares Held
77K
Value
$3.79M